Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neuroblastoma 7Recurrence 1Pheochromocytoma 1Paraganglioma 1Neuroendocrine Tumors 1Neoplasms 1Ganglioneuroblastoma 1

Interventions

Vincristine 2Topotecan 2Stem Cell Transplantation 2Radiation 2Platinum 2Melphalan 2Doxorubicin 2Cyclophosphamide 2Congresses as Topic 2Cisplatin 2Busulfan 21,2-diaminocyclohexaneplatinum II citrate 2etoposide phosphate 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Peripheral Blood Stem Cell Transplantation 1Mesna 1Isotretinoin 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 13-Iodobenzylguanidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Ganglioneuroblastoma × 3-Iodobenzylguanidine × Clear all
NCT01175356 2026-01-23

Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin

Children's Oncology Group

Phase 1 Completed
99 enrolled 11 charts
CNS

Neuroblastoma, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡